Trials / Enrolling By Invitation
Enrolling By InvitationNCT06928090
Efficacy and Safety of DTG/3TC in Treatment-naïve HIV-1 Infected Patients
A Retrospective Observational Study of Efficacy and Safety of DTG/3TC(Dolutegravir/Lamivudine) in Treatment-naïve HIV-1 Infected Patients From at Real-life Cohort in Korea
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Chungnam National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
Non-interventional, retrospective, single arm study of individuals who have initiated a DTG/3TC regimen. Medical chart will be reviewed by the investigators. Naive subjects will be identified by the clinic database as having initiated DTG/3TC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DTG + 3TC FDC | None(Non-interventional, retrospective chart review, single-arm study ) |
Timeline
- Start date
- 2025-01-24
- Primary completion
- 2025-12-30
- Completion
- 2027-01-30
- First posted
- 2025-04-15
- Last updated
- 2025-04-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06928090. Inclusion in this directory is not an endorsement.